- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on HER2 or EGFR Expressing Advanced Solid Malignancies
Total 464 results
-
Bristol-Myers SquibbCompletedHER2 or EGFR Expressing Advanced Solid MalignanciesSpain, France
-
GeneQuantum Healthcare (Suzhou) Co., Ltd.RecruitingHER2 Expressing or Mutated Advanced Malignant Solid TumorsChina
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingHER2-expressing Advanced Solid TumorsChina
-
Amunix, a Sanofi CompanyMerck Sharp & Dohme LLCRecruitingLocally Advanced or Metastatic HER2-Expressing CancersAustralia, Spain, France, Portugal
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.TerminatedHER2 Expressing Solid TumoursUnited States, Germany
-
Advaxis, Inc.CompletedHER2 Expressing Solid TumorsUnited States
-
Taiho Oncology, Inc.TerminatedAdvanced Solid Tumors With HER2 Abnormalities | Advanced Solid Tumors With HER3 AbnormalitiesUnited States, Spain, France, United Kingdom
-
Mirati Therapeutics Inc.Enrolling by invitationAdvanced or Metastatic Solid MalignanciesUnited States
-
Incyte CorporationTerminatedAdvanced or Metastatic Solid Tumors | FGFR Mutations | FGFR TranslocationsUnited States
-
Shanghai Hengrui Pharmaceutical Co., Ltd.RecruitingAdvanced Or Metastatic Solid Tumor MalignanciesChina
-
Novita Pharmaceuticals, Inc.RecruitingAdvanced or Metastatic Solid Tumor MalignanciesUnited States
-
BayerCompletedAdvanced CEACAM6-expressing Solid TumorsUnited States, Singapore, Canada
-
GigaGen, Inc.National Cancer Institute (NCI)RecruitingAdvanced or Metastatic Solid Tumor MalignanciesUnited States
-
University Medical Center GroningenActive, not recruitingLocally Advanced or Metastatic Solid Tumors Irrespective of PD-L1 ExpressionNetherlands
-
Puma Biotechnology, Inc.TerminatedSolid Tumors Harboring Somatic HER2 or EGFR Exon 18 MutationsFrance, United States, Spain, Belgium, United Kingdom, Serbia, Australia, Israel, Canada, Denmark, Ireland, Italy, Korea, Republic of
-
Chinese PLA General HospitalUnknownAdvanced EGFR-positive Solid TumorsChina
-
AHS Cancer Control AlbertaCross Cancer InstituteWithdrawnMetastatic Solid Malignancies | Locally Advanced Solid MalignanciesCanada
-
Astellas Pharma IncCompletedLocally Advanced (Unresectable) or Metastatic Solid Tumor MalignanciesJapan
-
Changchun Intellicrown Pharmaceutical Co. LTDCovanceRecruitingAdvanced EGFR Positive Solid TumorUnited States, China
-
Zhuhai Yufan Biotechnologies Co., LtdRecruitingAdvanced Solid Tumor | Advanced Solid MalignanciesChina
-
Zhuhai Yufan Biotechnologies Co., LtdRecruitingAdvanced Solid Tumor | Advanced Solid MalignanciesUnited States
-
National University Hospital, SingaporeRecruitingMetastatic Solid Malignancies | Advance Solid MalignanciesSingapore
-
AstraZenecaTerminatedCancer | Advanced Solid Tumors | Advanced Solid MalignanciesUnited States
-
AstraZenecaActive, not recruitingAdvanced Solid MalignanciesJapan
-
AstraZenecaActive, not recruitingAdvanced Solid MalignanciesRomania, Moldova, Republic of
-
Novartis PharmaceuticalsCompletedAdvanced Solid MalignanciesNetherlands
-
Samyang Biopharmaceuticals CorporationCompleted
-
AstraZenecaCompletedAdvanced Solid MalignanciesUnited Kingdom
-
Regeneron PharmaceuticalsSanofiCompletedAdvanced Solid MalignanciesUnited States
-
AstraZenecaCompletedAdvanced Solid MalignanciesChina
-
Mayo ClinicGlaxoSmithKlineCompletedAdvanced Solid MalignanciesUnited States
-
AstraZenecaCompletedCancer | Solid Tumors | Advanced Solid MalignanciesJapan
-
AstraZenecaTerminatedCancer | Solid Tumors | Advanced Solid MalignanciesJapan
-
Athenex, Inc.RecruitingAdvanced Solid MalignanciesUnited States
-
Carrick Therapeutics LimitedCompletedAdvanced Solid MalignanciesUnited States, United Kingdom
-
Novartis PharmaceuticalsCompletedAdvanced Solid MalignanciesFrance, Spain, Canada
-
AstraZenecaCompletedAdvanced Solid MalignanciesJapan
-
AstraZenecaCompletedAdvanced Solid MalignanciesJapan
-
Taipei Medical UniversityCompletedAdvanced Solid MalignanciesTaiwan
-
Hanmi Pharmaceutical Company LimitedCompletedAdvanced Solid MalignanciesKorea, Republic of
-
AstraZenecaCompleted10mg ZD4054 (Zibotentan) PK Study in Male, Elderly Chinese Patients With Advanced Solid MalignanciesAdvanced Solid MalignanciesChina
-
Bristol-Myers SquibbTerminatedAdvanced Solid MalignanciesUnited States, Canada
-
Georgiamune IncRecruitingAdvanced Solid MalignanciesUnited States
-
Janssen Research & Development, LLCRecruitingAdvanced Solid MalignanciesUnited States, Korea, Republic of, Canada, United Kingdom
-
Treadwell Therapeutics, IncTIO Discovery EngineRecruitingAdvanced Solid MalignanciesUnited States, Hong Kong, Canada
-
Oneness Biotech Co., Ltd.RecruitingAdvanced Solid MalignanciesTaiwan
-
AstraZenecaActive, not recruiting
-
Eucure (Beijing) Biopharma Co., LtdCompletedAdvanced Solid MalignanciesAustralia
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Solid MalignanciesUnited States, Spain
-
AstraZenecaCompleted